NEWS RELEASE: Chromogenic Factor VIII Assay Cleared for Sale in Canada, EU, Australia, and New Zealand

by Shana Cristoferi | Jan 20, 2020 | News, Precision BioLogic

January 20, 2020 Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce the availability of its new cryocheck Chromogenic Factor VIII assay in Canada, the European Union, Australia, and New Zealand following market...

News Release: Precision BioLogic Launches Product to Improve Inhibitor Testing for People with Hemophilia A

by administrator | Feb 11, 2019 | News, Precision BioLogic

HALIFAX, February 11, 2019—Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce the availability of its new CRYOcheck Factor VIII Inhibitor Kit in Canada, the European Union, Australia, and New Zealand following market...

Precision BioLogic Acquires Affinity Biologicals

by administrator | Nov 5, 2018 | News, Precision BioLogic

About Affinity Biologicals Affinity Biologicals Inc. was founded in 1987 by Hugh and Patricia Hoogendoorn. With a strong background in hemostasis research and a focus on reagent and assay development, Affinity has become a primary manufacturer of more than 300...

Working to Improve Hemophilia A Testing: Precision BioLogic presents new data at the 64th Annual SSC meeting

by administrator | Jul 19, 2018 | News, Precision BioLogic

See original release here For Immediate Release HALIFAX, July 19, 2018—Precision BioLogic today unveiled data from a study using a new kit for a Modified Nijmegen-Bethesda Assay (MNBA) at the International Society on Thrombosis and Haemostasis’ Scientific and...

ACOA: Precision BioLogic Inc. Banks on Developing New Diagnostic Tools

by administrator | May 11, 2018 | News, Precision BioLogic

See original press release here Precision BioLogic Inc. Banks on Developing New Diagnostic Tools From: Atlantic Canada Opportunities Agency News release Government of Canada supports research project to advance medical technology for clinical coagulation tests May 11,...

Precision BioLogic Presents New Approach to Standardize and Improve Inhibitor Testing for People with Hemophilia A

by administrator | Mar 13, 2018 | News, Precision BioLogic

See original release New data highlights promising performance of a new kit for use in a modified Nijmegen-Bethesda Assay For Immediate Release: HALIFAX, March 13, 2018—Precision BioLogic, in collaboration with Roche and Genentech, a member of the Roche Group,...